P.S. Free 2026 CBIC CIC dumps are available on Google Drive shared by Prep4sures: https://drive.google.com/open?id=1rwrfHC2rhmK0NpXrdjjycmPH63XS5vZK
The questions and answers of our CIC study tool have simplified the important information and seized the focus and are updated frequently by experts to follow the popular trend in the industry. Because of these wonderful merits the client can pass the exam successfully with high probability. It is easy for you to pass the exam because you only need 20-30 hours to learn and prepare for the exam. You may worry there is little time for you to learn the CIC Study Tool and prepare the exam because you have spent your main time and energy on your most important thing such as the job and the learning and canβt spare too much time to learn.
| Section | Weight | Objectives |
|---|---|---|
| Topic 1: Surveillance and Epidemiologic Investigation | 24% | - Benchmarking and reporting - Outbreak investigation and response - Surveillance system design and implementation - Data collection, validation, and analysis |
| Topic 2: Environment of Care | 10% | - Water and air quality management - Facility design, construction, and renovation - Waste management and environmental services - Safety and risk assessment |
| Topic 3: Identification of Infectious Disease Processes | 19% | - Emerging and re-emerging pathogens - Microbiology and pathogenesis - Risk factors and transmission mechanisms - Epidemiologic principles |
| Topic 4: Prevention and Control of Transmission of Infectious Agents | 28% | - Standard and transmission-based precautions - Cleaning, disinfection, and sterilization - Antimicrobial stewardship - Isolation and patient placement - Hand hygiene and aseptic techniques |
| Topic 5: Education, Research, and Quality Improvement | 9% | - Evidence-based practice and research application - Regulatory and accreditation compliance - Performance measurement and quality improvement - Development and delivery of education programs |
| Topic 6: Employee and Occupational Health | 10% | - Immunization programs - Health screening and surveillance - Workplace safety policies - Exposure management and post-exposure prophylaxis |
Many students often start to study as the exam is approaching. Time is very valuable to these students, and for them, one extra hour of study may mean 3 points more on the test score. If you are one of these students, then CBIC Certified Infection Control Exam exam tests are your best choice. Because students often purchase materials from the Internet, there is a problem that they need transport time, especially for those students who live in remote areas. When the materials arrive, they may just have a little time to read them before the exam. However, with CIC Exam Questions, you will never encounter such problems, because our materials are distributed to customers through emails.
NEW QUESTION # 92
A patient with fever, rash, and meningoencephalitis is admitted to the hospital, placed in Droplet Precautions, and started on antibiotic therapy. Bacterial cultures of the blood and spinal fluid are negative, and infection with West Nile virus is strongly suspected by the infectious disease consultant. Appropriate control measures should include:
Answer: D
Explanation:
West Nile virus (WNV) is a mosquito-borne infection. In routine healthcare and household settings, WNV is not spread through coughing, sneezing, or touching and is not transmitted by casual person-to-person contact. Because Transmission-Based Precautions (e.g., Droplet) are used when there is evidence or strong concern for transmission via droplet/contact/airborne routes, WNV suspicion does not justify continuing Droplet Precautions once other droplet-spread causes are no longer suspected.
CDC isolation guidance principles indicate that when there is no evidence for person-to-person transmission by droplet, contact, or airborne routes, Standard Precautions are appropriate. Therefore, the correct action is to discontinue Droplet Precautions and manage the patient using Standard Precautions (hand hygiene and appropriate PPE based on anticipated exposure to blood/body fluids).
The other options are not indicated: immunoglobulin for family members is not a standard infection control measure for WNV, quarantining a pet parakeet is irrelevant to WNV transmission, and "continuing present measures" would unnecessarily maintain Droplet Precautions without a transmission-based indication.
NEW QUESTION # 93
A healthcare professional in a clinical microbiology laboratory is concerned about routine exposure to Neisseria meningitidis in culture. The healthcare professional last received the Meningococcal vaccine 8 years ago. What recommendation should be given to the healthcare professional regarding their meningococcal vaccination?
Answer: B
Explanation:
The correct answer is B, "They are due for a booster as it has been over 7 years," as this is the appropriate recommendation for the healthcare professional regarding their meningococcal vaccination. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, which align with recommendations from the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP), healthcare professionals with routine exposure to Neisseria meningitidis, such as those in clinical microbiology laboratories, are at increased risk of meningococcal disease due to potential aerosol or droplet exposure during culture handling. The quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended for such individuals, with a primary series (one dose for those previously vaccinated or two doses 2 months apart for unvaccinated individuals) and a booster dose every 5 years if the risk persists (CDC Meningococcal Vaccination Guidelines, 2021). However, for laboratory workers with ongoing exposure, the ACIP specifies a booster interval of every 5 years from the last dose, but this is often interpreted in practice as aligning with the 5-7 year range depending on risk assessment and institutional policy. Since the healthcare professional received the vaccine 8 years ago and works in a high- risk setting, a booster is due, with the 7-year threshold being a practical midpoint for this scenario (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents).
Option A (they are due for a booster as it has been over 5 years) is close but slightly premature based on the 8- year interval, though it reflects the general 5-year booster guideline for high-risk groups; the 7-year option better matches the specific timeframe. Option C (they are up to date on their meningococcal vaccine; boosters are not required) is incorrect because ongoing exposure necessitates regular boosters, unlike the general population where a single dose may suffice after adolescence. Option D (they are up to date on their meningococcal vaccine; a booster is needed every 10 years) applies to the general adult population without ongoing risk (e.g., post-adolescence vaccination), not to laboratory workers with continuous exposure, where the interval is shorter.
The recommendation for a booster aligns with CBIC's emphasis on protecting healthcare personnel from occupational exposure to communicable diseases, ensuring compliance with evidence-based immunization practices (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.1 - Collaborate with organizational leaders). This supports the prevention of meningococcal disease outbreaks in healthcare settings.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.1 - Collaborate with organizational leaders, 3.2 - Implement measures to prevent transmission of infectious agents. CDC Meningococcal Vaccination Guidelines, 2021. ACIP Recommendations for Meningococcal Vaccines, 2020 (updated 2023).
NEW QUESTION # 94
A family, including an infant of 8 months, is going on a vacation to Europe. An infection preventionist would recommend:
Answer: A
Explanation:
When advising a family, including an 8-month-old infant, planning a vacation to Europe, an infection preventionist (IP) must consider travel-related health risks and vaccination recommendations tailored to the destination and age-specific guidelines. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes the "Education and Training" domain, which includes providing evidence-based advice to prevent infections, aligning with the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) travel health recommendations.
Option D, "Family immunization records should be reviewed by their provider," is the most appropriate recommendation. Europe, as a region, includes countries with varying health risks, but it is generally considered a low-risk area for many vaccine-preventable diseases compared to tropical regions. The CDC's
"Travelers' Health" guidelines (2023) recommend that all travelers, including infants, have their immunization status reviewed by a healthcare provider prior to travel to ensure compliance with routine vaccinations (e.g., measles, mumps, rubella [MMR], diphtheria, tetanus, pertussis [DTaP], and polio) and to assess any destination-specific needs. For an 8-month-old, the review would confirm that the infant has received age-appropriate vaccines (e.g., the first doses of DTaP, Hib, PCV, and IPV, typically starting at 2 months) and is on schedule for the 6- and 12-month doses. This step ensures the family's overall protection and identifies any gaps, making it a proactive and universally applicable recommendation.
Option A, "Exposure to rabies should be avoided," is a general travel safety tip applicable to any destination where rabies is endemic (e.g., parts of Eastern Europe or rural areas with wildlife). However, rabies risk in most European countries is low, and pre-exposure vaccination is not routinely recommended for travelers unless specific high-risk activities (e.g., handling bats) are planned. The CDC advises avoiding animal bites rather than vaccinating unless indicated, making this less specific and urgent than a records review. Option B,
"Family members should be vaccinated for yellow fever," is incorrect. Yellow fever is not endemic in Europe, and vaccination is not required or recommended for travel to any European country. The WHO International Health Regulations (2005) and CDC list yellow fever vaccination as mandatory only for travelers from or to certain African and South American regions, rendering this irrelevant. Option C, "The infant should not travel until at least 12 months of age," lacks a clear evidence base. While some vaccines (e.g., MMR) are typically given at 12 months, the 8-month-old can travel safely if up-to-date on age-appropriate immunizations. The CDC allows travel for infants as young as 6 weeks with medical clearance, and delaying travel to 12 months is not a standard recommendation unless specific risks (e.g., disease outbreaks) are present, which are not indicated here.
The CBIC Practice Analysis (2022) and CDC Travelers' Health resources prioritize pre-travel health assessments, including immunization reviews, as the foundation for safe travel. Option D ensures a comprehensive approach tailored to the family's needs, making it the best recommendation for a trip to Europe.
References:
* CBIC Practice Analysis, 2022.
* CDC Travelers' Health, 2023.
* WHO International Health Regulations, 2005.
The correct answer is B, "Blood pressure cuff," as this item is appropriately cleaned with a disinfectant that is an approved hospital disinfectant with no tuberculocidal claim. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the selection of disinfectants for medical equipment depends on the item's classification and intended use. The Environmental Protection Agency (EPA) categorizes hospital disinfectants based on their efficacy against specific pathogens, with tuberculocidal claims indicating effectiveness against Mycobacterium tuberculosis, a highly resistant organism. A disinfectant without a tuberculocidal claim is suitable for non-critical items-those that contact intact skin but not mucous membranes or sterile tissues-such as blood pressure cuffs, which require only low-level disinfection to reduce bacterial and viral loads (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 - Implement environmental cleaning and disinfection protocols).
This aligns with CDC guidelines, which designate low-level disinfectants as adequate for non-critical surfaces.
Option A (laryngoscope blades) is incorrect because laryngoscope blades are semi-critical items that contact mucous membranes (e.g., the oropharynx) and require high-level disinfection or sterilization, which necessitates a disinfectant with tuberculocidal activity to ensure efficacy against a broader spectrum of pathogens, including mycobacteria. Option C (respiratory therapy equipment) is also incorrect, as this equipment (e.g., ventilators or nebulizers) is semi-critical or critical depending on its use, requiring at least intermediate- to high-level disinfection, which exceeds the capability of a non-tuberculocidal disinfectant.
Option D (ultrasound probe) is inappropriate if used on intact skin (non-critical, allowing low-level disinfection), but many ultrasound probes contact mucous membranes or sterile sites, necessitating high-level disinfection with a tuberculocidal agent, making this option unreliable without context.
The selection of a blood pressure cuff aligns with CBIC's emphasis on using appropriate disinfectants based on the Spaulding classification to prevent healthcare-associated infections (HAIs) (CBIC Practice Analysis,
2022, Domain III: Infection Prevention and Control, Competency 3.5 - Evaluate the environment for infection risks). This is supported by EPA and CDC guidelines, which guide disinfectant use based on item risk levels (EPA Disinfectant Product List, 2023; CDC Disinfection Guidelines, 2019).
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.4 - Implement environmental cleaning and disinfection protocols, 3.5 - Evaluate the environment for infection risks. EPA Disinfectant Product List, 2023. CDC Guidelines for Disinfection and Sterilization in Healthcare Facilities, 2019.
NEW QUESTION # 95
An infection preventionist (IP) believes that there is an increase in transmission of healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) infections in the surgical intensive care unit. Which of the following would allow the IP to assess whether there is an increase in the rate of healthcare-associated MRSA infections?
Answer: B
Explanation:
The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that incidence rate is the most appropriate epidemiologic measure to assess whether there is an increase in transmission of healthcare- associated infections, including methicillin-resistant Staphylococcus aureus (MRSA). Incidence measures the number of new cases occurring in a defined population over a specific period of time, making it the key indicator for evaluating changes in infection risk and ongoing transmission.
When an infection preventionist suspects an increase in healthcare-associated MRSA infections, the primary concern is whether new cases are occurring more frequently than expected. Incidence rate allows comparison over time (e.g., month-to-month or quarter-to-quarter) and can be standardized using appropriate denominators such as patient days or device days. This enables detection of trends, clusters, or outbreaks and supports timely intervention.
Prevalence rate (Option C) reflects the total number of existing cases at a given point in time, including both old and new infections. While useful for understanding disease burden, prevalence cannot distinguish between ongoing transmission and prolonged duration of existing cases. Mortality rate (Option A) and case fatality rate (Option D) measure outcomes of infection severity, not transmission or acquisition.
For the CIC exam, it is critical to recognize that incidence rate is the correct measure for assessing increases in healthcare-associated infection transmission, making it the best choice for this scenario.
NEW QUESTION # 96
The infection preventionist understands that the heating, ventilation and air conditioning (HVAC) systems in the facility can be a risk factor for healthcare-acquired infections. What is the MOST likely risk from the HVAC system for patients in a Pediatric Oncology unit?
Answer: A
Explanation:
Patients in pediatric oncology units are highly immunocompromised, making them particularly susceptible to opportunistic fungal infections such asAspergillusspp. HVAC systems, especially if improperly maintained or contaminated, can disseminate fungal spores into patient care areas.
* According to theAPIC Text (Chapter 116 - HVAC Systems), fungal spores such asAspergilluscan be transmitted via HVAC systems. These infections have been linked to contaminated air ducts, faulty air filters, and construction-related air disturbances. Outbreaks of aspergillosis are frequently associated with construction near patient care areas and are particularly dangerous for immunocompromised patients, including pediatric oncology patients.
* Additional data fromAPIC Text (Chapter 45 - Infection Prevention in Oncology Patients)reinforces thatAspergillusspp. infections in oncology and immunocompromised patients are primarily airborne and are most often disseminated via HVAC systems.
* Incorrect answer rationale:
* A. MRSA- Typically spread via direct contact, not HVAC.
* B. Norovirus- Spread via fecal-oral route and contaminated surfaces, not airborne HVAC.
* D.Clostridioides difficile- Spread via contact with spores on surfaces, not through the air.
References:
APIC Text, 4th Edition, Chapter 116 - Heating, Ventilation, and Air Conditioning APIC Text, 4th Edition, Chapter 45 - Infection Prevention in Oncology and Immunocompromised Patients
NEW QUESTION # 97
......
In the process of using the CBIC Certified Infection Control Exam study training dumps, once users have any questions about our study materials, the user can directly by E-mail us, our products have a dedicated customer service staff to answer for the user, they are 24 hours service for you, we are very welcome to contact us by E-mail and put forward valuable opinion for us. Our CIC latest questions already have many different kinds of learning materials, users may be confused about the choice, what is the most suitable CIC Test Guide? Believe that users will get the most satisfactory answer after consultation. Our online service staff is professionally trained, and users' needs about CIC test guide can be clearly understood by them. The most complete online service of our company will be answered by you, whether it is before the product purchase or the product installation process, or after using the CIC latest questions, no matter what problem the user has encountered.
Reliable CIC Braindumps Book: https://www.prep4sures.top/CIC-exam-dumps-torrent.html
P.S. Free 2026 CBIC CIC dumps are available on Google Drive shared by Prep4sures: https://drive.google.com/open?id=1rwrfHC2rhmK0NpXrdjjycmPH63XS5vZK